Thomas Seufferlein
Thomas Seufferlein is a gastroenterologist and cancer specialist at the University Hospital Ulm in Germany, recognized for his expertise in treating pancreatic cancer. He has been vocal about the potential of the new drug Daraxonrasib and its implications for early intervention in cancer treatment.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Switzerland | 1 | 8.00 | 0.08% | +0% | 8,654,622 | 6,985 | $700,000 | 565$ |
| Totals | 1 | 8,654,622 | 6,985 | $700,000 | 565$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Thomas Seufferlein is a cancer specialist and gastroenterologist from the University Hospital Ulm who discussed the potential benefits of administering the drug earlier.
8